Literature DB >> 21533863

Genetic influences on Alzheimer's disease: evidence of interactions between the genes APOE, APOC1 and ACE in a sample population from the South of Brazil.

Juliana Fagion Lucatelli1, Alessandra Chielle Barros, Vanessa Kappel da Silva, Fernanda da Silva Machado, Pâmela Camini Constantin, Ana Amélia Cipriani Dias, Mara Helena Hutz, Fabiana Michelsen de Andrade.   

Abstract

Alzheimer's disease is a complex neurodegenerative disorder. Several genes have been suggested as Alzheimer's susceptibility factors, the apolipoprotein E (APOE) gene being an established susceptibility gene and the genes coding angiotensin-converting enzyme (ACE) and apolipoprotein C1 (APOC1) being considered possible candidate genes for the disease. The objective of this study was to investigate the association of ACE and APOC1 gene polymorphisms with susceptibility to Alzheimer's disease and dementia in general, both alone and combined with the APOE gene. Forty-seven patients with dementia in general (35 of them with Alzheimer's disease) and 85 controls were investigated. The haplotypes E*3/-317*ins and E*4/-317*ins of APOE/APOC1 genes were significantly more frequent in the groups with Alzheimer's disease and dementia in general (P < 0.001). The frequency of the ACE*ins allele was also greater in the groups with Alzheimer's disease and dementia in general (P = 0.022; P = 0.045), but genotype frequencies were only different in groups without the E*4/-317*ins haplotype (P = 0.012 for Alzheimer's disease; P = 0.04 for dementia). Our data point to important genetic interactions involved in these diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21533863     DOI: 10.1007/s11064-011-0481-7

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  30 in total

1.  Human ApoCI HpaI restriction site polymorphism revealed by the polymerase chain reaction.

Authors:  W M Nillesen; H J Smeets; B A van Oost
Journal:  Nucleic Acids Res       Date:  1990-06-11       Impact factor: 16.971

2.  Association of apolipoproteins e4 and c1 with onset age and memory: a study of sporadic Alzheimer disease in Taiwan.

Authors:  Wen-Li Chuang; Yu-Chen Hsieh; Chun-Yi Wang; Hung-Chou Kuo; Chin-Chang Huang
Journal:  J Geriatr Psychiatry Neurol       Date:  2010-03       Impact factor: 2.680

3.  Haplotypes extending across ACE are associated with Alzheimer's disease.

Authors:  Patrick G Kehoe; Hagit Katzov; Lars Feuk; Anna M Bennet; Boo Johansson; Björn Wiman; Ulf de Faire; Nigel J Cairns; Gordon K Wilcock; Anthony J Brookes; Kaj Blennow; Jonathan A Prince
Journal:  Hum Mol Genet       Date:  2003-04-15       Impact factor: 6.150

4.  An age effect on the association of common variants of ACE with Alzheimer's disease.

Authors:  Nicole Helbecque; Valerie Codron; Dominique Cottel; Philippe Amouyel
Journal:  Neurosci Lett       Date:  2009-06-17       Impact factor: 3.046

5.  Apolipoprotein E genotyping methods for the clinical laboratory.

Authors:  B Maekawa; T G Cole; R L Seip; D Bylund
Journal:  J Clin Lab Anal       Date:  1995       Impact factor: 2.352

6.  Assessment of Alzheimer's disease case-control associations using family-based methods.

Authors:  Brit-Maren M Schjeide; Matthew B McQueen; Kristina Mullin; Jason DiVito; Meghan F Hogan; Michele Parkinson; Basavaraj Hooli; Christoph Lange; Deborah Blacker; Rudolph E Tanzi; Lars Bertram
Journal:  Neurogenetics       Date:  2008-10-02       Impact factor: 2.660

Review 7.  Angiotensin-converting enzyme and its clinical significance--a review.

Authors:  P R Studdy; R Lapworth; R Bird
Journal:  J Clin Pathol       Date:  1983-08       Impact factor: 3.411

8.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

Review 9.  Angiotensin-converting enzyme 2 in the brain: properties and future directions.

Authors:  Huijing Xia; Eric Lazartigues
Journal:  J Neurochem       Date:  2008-11-05       Impact factor: 5.372

Review 10.  Brain renin angiotensin in disease.

Authors:  M Ian Phillips; Edilamar Menezes de Oliveira
Journal:  J Mol Med (Berl)       Date:  2008-04-02       Impact factor: 4.599

View more
  15 in total

1.  Sleep and Late-Onset Alzheimer's Disease: Shared Genetic Risk Factors, Drug Targets, Molecular Mechanisms, and Causal Effects.

Authors:  Dongze Chen; Xinpei Wang; Tao Huang; Jinzhu Jia
Journal:  Front Genet       Date:  2022-05-17       Impact factor: 4.772

Review 2.  Evolution of genetic and genomic features unique to the human lineage.

Authors:  Majesta O'Bleness; Veronica B Searles; Ajit Varki; Pascal Gagneux; James M Sikela
Journal:  Nat Rev Genet       Date:  2012-12       Impact factor: 53.242

3.  Association between ACE polymorphism, cognitive phenotype and APOE E4 allele in a Tunisian population with Alzheimer disease.

Authors:  Afef Achouri-Rassas; Nadia Ben Ali; Aroua Cherif; Saloua Fray; Hajer Siala; Nouria Oudiaa Zakraoui; Sondes Hadj-Fredj; Mariem Kechaou; Nadia Anane; Slim Echebi; Taieb Messaoud; Samir Belal
Journal:  J Neural Transm (Vienna)       Date:  2015-10-12       Impact factor: 3.575

4.  ACE polymorphism and use of ACE inhibitors: effects on memory performance.

Authors:  Jaqueline B Schuch; Pamela C Constantin; Vanessa K da Silva; Camila Korb; Daiani P Bamberg; Tatiane J da Rocha; Marilu Fiegenbaum; Alcyr de Oliveira; Luciana A Tisser; Fabiana M de Andrade
Journal:  Age (Dordr)       Date:  2014-04-04

5.  Angiotensin-converting enzyme insertion/deletion polymorphism is not a major determining factor in the development of sporadic Alzheimer disease: evidence from an updated meta-analysis.

Authors:  Xue-bin Wang; Ning-hua Cui; Jie Yang; Xue-ping Qiu; Jia-jia Gao; Na Yang; Fang Zheng
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240

6.  Comprehensive evaluation of the association of APOE genetic variation with plasma lipoprotein traits in U.S. whites and African blacks.

Authors:  Zaheda H Radwan; Xingbin Wang; Fahad Waqar; Dilek Pirim; Vipavee Niemsiri; John E Hokanson; Richard F Hamman; Clareann H Bunker; M Michael Barmada; F Yesim Demirci; M Ilyas Kamboh
Journal:  PLoS One       Date:  2014-12-12       Impact factor: 3.240

7.  Angiotensin converting enzyme inhibitors and the reduced risk of Alzheimer's disease in the absence of apolipoprotein E4 allele.

Authors:  Wei Qiao Qiu; Mkaya Mwamburi; Lilah M Besser; Haihao Zhu; Huajie Li; Max Wallack; Leslie Phillips; Liyan Qiao; Andrew E Budson; Robert Stern; Neil Kowall
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

8.  Association between APOC1 polymorphism and Alzheimer's disease: a case-control study and meta-analysis.

Authors:  Qin Zhou; Fan Zhao; Ze-ping Lv; Chen-guang Zheng; Wei-dong Zheng; Liang Sun; Na-na Wang; Shenghang Pang; Fabiana Michelsen de Andrade; Mian Fu; Xiang-hua He; Juan Hui; WenyYu Jiang; Chu-yu Yang; Xiao-hong Shi; Xiao-quan Zhu; Guo-fang Pang; Yi-ge Yang; Hai-qun Xie; Wan-dong Zhang; Cai-you Hu; Ze Yang
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

9.  Gene expression profiling of brains from bovine spongiform encephalopathy (BSE)-infected cynomolgus macaques.

Authors:  Maura Barbisin; Silvia Vanni; Ann-Christin Schmädicke; Judith Montag; Dirk Motzkus; Lennart Opitz; Gabriela Salinas-Riester; Giuseppe Legname
Journal:  BMC Genomics       Date:  2014-06-05       Impact factor: 3.969

10.  Analysis of the placental tissue transcriptome of normal and preeclampsia complicated pregnancies.

Authors:  E A Trifonova; T V Gabidulina; N I Ershov; V N Serebrova; A Yu Vorozhishcheva; V A Stepanov
Journal:  Acta Naturae       Date:  2014-04       Impact factor: 1.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.